Publication | Open Access
PDE5 Inhibition Ameliorates Visceral Adiposity Targeting the miR-22/SIRT1 Pathway: Evidence From the CECSID Trial
60
Citations
38
References
2016
Year
Treatment with PDE5i in humans and murine models of diabetes improves VAT, targeting SIRT1 through a modulation of miR-22-3p expression.
| Year | Citations | |
|---|---|---|
Page 1
Page 1